Vitamin C Benefits: What Human Studies Show, Doses, Safety

Vitamin C (L-ascorbic acid) is an essential vitamin your body cannot make, and the one benefit that is firmly established is that it prevents and cures scurvy. For everything else, such as colds, blood pressure, cancer and heart disease, human studies of supplements are small, mixed or mostly negative, partly because most people already get enough from food. This page walks through each studied use, the doses researchers used, and the safety limits.

Quick facts

What the human evidence shows

The uses below run from strongest evidence to weakest. A note on why so many results are disappointing: the body tightly controls vitamin C levels. The NIH fact sheet says cells appear saturated at daily intakes of 100 mg or more, and at 200 mg or more plasma levels rise only marginally. A review in the British Journal of Nutrition adds that people already saturated through diet excrete the surplus and are unlikely to benefit from more.

Preventing and treating scurvy and low vitamin C

The NIH Office of Dietary Supplements fact sheet says vitamin C is required to make collagen, L-carnitine and certain neurotransmitters, and it improves absorption of nonheme iron (the iron in plant foods). Too little causes scurvy: fatigue, bleeding gums, bruising, joint pain, poor wound healing and corkscrew hairs. Signs can appear within a month of getting less than about 10 mg a day. Scurvy is rare in developed countries but can occur in people with limited food variety. This evidence goes back to 1700s citrus experiments by the naval surgeon James Lind, and it is the clearest benefit of vitamin C. The groups the NIH lists as more likely to fall short are people who smoke or are exposed to secondhand smoke, infants fed evaporated or boiled milk, people with limited food variety, and people with malabsorption or certain chronic diseases.

Common cold

Is vitamin C for colds a myth? Partly. Everyday Health, citing the NIH, says there is no evidence that high levels of vitamin C prevent the common cold in the general population. It says vitamin C may shorten a cold or ease its severity, but only if you were already taking it consistently before getting sick. Healthdirect Australia says there is some research that vitamin C may reduce the length of severe cold symptoms. Denver Health Medical Plan says it cannot cure a cold in progress. Everyday Health also reports a 2020 review in Frontiers in Immunology suggesting vitamin C might lower the rate of colds in athletes under short periods of extreme physical stress. So the evidence is modest and mixed, not a clear benefit and not clearly a myth.

Blood pressure

A 2026 umbrella review in Food & Function pooled six meta-analyses covering 17 randomized trials. It found vitamin C may lower systolic blood pressure (the top number) by about 3.7 mmHg. Diastolic pressure did not fall overall, though people with diabetes saw a reduction of 2.27 mmHg. The authors rated the certainty of the evidence as low and called for larger, longer trials. Everyday Health describes a 2020 meta-analysis of eight randomized trials with over 600 participants, with an average dose near 500 mg, that found a significant drop in people with high blood pressure. An earlier CMAJ commentary noted that small short-term studies showed lower systolic pressure while larger studies were inconsistent. Blood pressure is a stand-in measure rather than a health outcome; our guide on surrogate outcomes explains why that matters.

Cancer prevention

The NIH fact sheet says case-control studies link higher dietary vitamin C to lower risk of several cancers, but prospective cohort results are inconsistent and most randomized trials found no effect on cancer risk. Examples it lists:

• SU.VI.MAX (13,017 French adults, 120 mg vitamin C plus vitamin E, beta-carotene, selenium and zinc, median 7.5 years): total cancer fell in men but not in women.
• Physicians’ Health Study II (500 mg vitamin C plus vitamin E every other day, mean 8 years): no reduction in prostate or total cancer.
• Women’s Antioxidant Cardiovascular Study (500 mg/day, mean 9.4 years): no significant effect on cancer incidence or mortality.
• Linxian, China (120 mg vitamin C plus molybdenum, 5 to 6 years): no significant effect on esophageal or gastric cancer.

The NIH notes a big limit: many trials never measured vitamin C levels before or after, so people already near saturation could not be expected to improve.

Cancer treatment, oral and IV

The NIH fact sheet reports that 1970s studies suggested benefit from high-dose vitamin C in terminal cancer, but a randomized, placebo-controlled Mayo Clinic trial gave 10 g/day to patients with advanced colorectal cancer, and they fared no better than placebo. Researchers have suggested the difference might be the route: oral doses top out at a plasma concentration of about 220 micromoles/L, while IV dosing can reach far higher. A 2026 systematic review of high-dose IV vitamin C found oncology phase I and II studies showing safety and quality-of-life improvements, and one randomized phase II pancreatic cancer trial that reported a promising survival benefit when combined with chemotherapy. It concluded that the role in cancer is supportive and exploratory, and that evidence does not support routine IV use in sepsis. IV vitamin C is a hospital or clinic treatment, not something a tablet can replicate, and it is not a substitute for cancer treatment.

Heart and blood vessel disease

The NIH fact sheet says observational results conflict. The Nurses’ Health Study (85,118 women over 16 years) tied total vitamin C intake from diet plus supplements to lower coronary heart disease risk, but diet alone showed no significant link. A pooled analysis of nine cohorts (293,172 people) found 25% lower coronary heart disease risk at 700 mg/day or more of supplemental vitamin C, while a 2008 meta-analysis of 14 cohorts found that dietary, but not supplemental, vitamin C was linked to lower risk. A much smaller study found postmenopausal women with diabetes taking at least 300 mg/day were more likely to die from cardiovascular disease.

Randomized trials mostly show no benefit. The Women’s Antioxidant Cardiovascular Study (8,171 women with prior cardiovascular disease, 500 mg/day, mean 9.4 years) and Physicians’ Health Study II (500 mg/day, mean 8 years) found no effect on major cardiovascular events. In the Women’s Angiographic Vitamin and Estrogen study (423 postmenopausal women), 500 mg vitamin C plus 400 IU vitamin E twice daily gave no cardiovascular benefit and significantly increased all-cause mortality compared with placebo. Observational studies like these cannot separate vitamin C from the rest of a fruit-and-vegetable diet or lifestyle, which is a point our guide to evaluating evidence quality covers.

Severe COVID-19

A 2026 meta-analysis in Clinical and Investigative Medicine pooled eight randomized trials with 2,104 COVID-19 patients. The pooled odds ratio for death was 0.97 (95% CI 0.80 to 1.18), meaning no significant difference between high-dose vitamin C and no vitamin C. The authors’ conclusion is more hopeful, saying it might reduce mortality in critically ill patients but varied by study, and that more research is needed. The numbers themselves show no clear effect. To see how pooling works, read our explainer on meta-analyses and systematic reviews.

People on hemodialysis

A 2026 systematic review in Nutrients (37 studies) found that people on hemodialysis commonly have low vitamin C. Most clinical studies supported a benefit for functional iron deficiency and restless legs syndrome, but effects on inflammation markers were inconsistent, and the authors said current data do not justify routine use for other problems. Anyone on dialysis should treat this as a conversation for their kidney team.

Exercise recovery

A 2026 meta-analysis in Clinical Nutrition ESPEN pooled 12 small placebo-controlled trials. It found no significant effect on IL-6 (2 trials, 31 people) or MDA, an oxidative stress marker (3 trials, 41 people). CRP, an inflammation marker, fell significantly (2 trials, 52 people). Certainty was low to very low, and the authors called the findings hypothesis-generating.

Eye health

Everyday Health, citing the NIH, says vitamin C might lower the risk of age-related macular degeneration and cataracts, and that the American Academy of Ophthalmology says 500 mg/day combined with vitamin E, zinc, copper, lutein and zeaxanthin may lower the risk of progression in people who already have AMD. It also reports a 2020 review in which benefit against cataracts appeared mainly in people who were deficient to begin with. The role of vitamin C alone remains unclear.

Hair

Is vitamin C good for hair? The documented link is deficiency. The NIH lists corkscrew hairs as a sign of scurvy, and Healthdirect lists hair loss among symptoms of too little vitamin C. If your intake is adequate, none of the studies cited here show that extra vitamin C grows or thickens hair. Hair loss has many causes, so ask a clinician before assuming a vitamin gap.

Doses used in studies

These are amounts researchers used, not recommendations.

What happens at 500 mg a day? According to the NIH, 70% to 90% of vitamin C is absorbed at 30 to 180 mg/day, and absorption drops below 50% above 1 g/day, with unmetabolized vitamin C excreted in urine. So at 500 mg you absorb a smaller share than at lower intakes. In the long trials above, 500 mg/day did not change cancer or cardiovascular outcomes.

What about 1,000 mg or 10,000 mg? Healthdirect Australia says not to take more than 1,000 mg a day as a supplement. Everyday Health, citing the NIH, gives a tolerable upper limit of 2,000 mg a day for adults, with diarrhea the main effect above that. No study in this page’s sources shows a clear benefit from 10,000 mg; the one cancer trial at that dose found none.

What about 10,000 IU? The studies here report vitamin C in mg or grams, and none gives an IU figure for it. Check the milligram amount on the label instead.

How much per day for a woman? The US Recommended Dietary Allowance is 75 mg for adult women, 85 mg in pregnancy and 120 mg while breastfeeding, plus 35 mg more for people who smoke. Australia’s reference intake is lower, at 45 mg for adults, 55 to 60 mg in pregnancy and 80 to 85 mg in breastfeeding, per Healthdirect. The NIH says the US figures are well above what prevents deficiency, and that five varied servings of fruit and vegetables can provide more than 200 mg.

Safety, side effects and medicine interactions

Healthdirect says that taken as directed, oral vitamin C does not usually cause serious side effects. It lists these effects of taking too much:

If you think you took too much, Healthdirect points Australian readers to the Poisons Information Centre on 13 11 26.

Who should talk to a clinician first

No source here names a group that must never take vitamin C, but several name people who should check first:

• Anyone having chemotherapy or radiation (the NIH says to consult the oncologist first).
• Anyone taking prescription medicines, such as statins (Everyday Health, citing the NIH).
• People with a history of kidney stones or kidney disease, or on dialysis.
• People with G6PD deficiency, before any IV high-dose treatment.
• Postmenopausal women with diabetes, since one small study linked 300 mg/day or more to more cardiovascular deaths (NIH).
• Anyone pregnant or breastfeeding, and parents considering supplements for children. Healthdirect advises speaking to a doctor or dietitian before any supplement.

Healthdirect says supplements may be advised for people with a diagnosed deficiency, a restrictive diet or conditions that affect absorption. Your clinician decides whether that applies to you. Never use vitamin C in place of a prescribed medicine, and do not stop or change a medicine because of anything on this page.

What is still unknown

• The British Journal of Nutrition review found that no trial it examined required low vitamin C at the start, and only 5 of 35 studies tested vitamin C alone. It concluded the effect of vitamin C as a single supplement cannot yet be judged, and that high-quality trials in people with defined low status have not been done.
• Whether vitamin C levels above what prevents scurvy bring any clinical benefit is unclear, according to the CMAJ commentary by NIH researchers.
• Whether IV dosing helps in cancer is still exploratory.
• Time of day: none of the sources identify a time that matters, so ask a pharmacist if you want advice on timing.
• Rules for ascorbic acid in Europe are not covered by these sources. Reference intakes differ by country, as the US and Australian figures above show, so check with a pharmacist or your national health authority.

How to read a label that lists vitamin C

• Amount: Find the milligrams per serving and how many tablets make a serving. The US Daily Value for adults is 90 mg (NIH), so a 1,000 mg tablet is far above it.
• Form: Ascorbic acid and the ascorbate salts all count as vitamin C. This answers the ascorbic acid versus vitamin C question: ascorbic acid is the chemical name of the vitamin and the most common supplement form. The NIH says supplemental ascorbic acid is absorbed as well as the kind in food. For combination forms, one study found higher white blood cell levels while another found no difference in plasma levels or urinary loss, and the authors of the latter concluded plain ascorbic acid is the preferred source.
• Add it all up: Multivitamins usually contain vitamin C. The NIH reports about 35% of US adults take a multivitamin and 12% a separate vitamin C supplement. Count food, multivitamins and any extra tablets against the upper limit.
• Blends: If vitamin C sits inside a blend that shows only a total weight, you cannot tell how much vitamin C you are getting. Look for a product that lists it on its own line, or ask the maker.

By ClinicalStudyConnect.com Research Desk